kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the ANIX dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for ANIX.

ANIX

Anixa Biosciences Inc
Healthcare · Biotechnology
$151.78 sample
-0.77 (-0.50%) 1D
☆ Watch
Market cap
$597.4B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-26
Alerts
8
Price$151.78 +14.23% 3M daily closessample
152.55131.71
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 26SEC10-Q filed
  • Oct 16INSInsider sell: Chief Executive Officer
  • Oct 09INSInsider sell: 10% owner
  • Oct 01SEC8-K filed: material event
  • Sep 25INSInsider sell: 10% owner
  • Sep 17INSInsider sell: Director
  • Sep 08INSInsider buy: EVP, Operations
  • Aug 28INSInsider buy: Director
Sign up to see the real ANIX record →

Company facts

SEC EDGAR registration
Name
Anixa Biosciences Inc
Sector
Healthcare
Industry
Biotechnology
Smart-money score
-23sample, -100 to +100
Reporting currency
USD

Who is positioning in ANIX

sample
Insiders
26 insider transactions over 90 days, net selling, $505.7M
Congress
No member trades over 90 days
Institutions · 13F
20 funds hold $10.2B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$18.6B +20.2% y/y
Q4 2024Q3 2026
Inventory$11.3B +12.0% y/y
Q4 2024Q3 2026
Accounts receivable$8.4B +21.4% y/y
Q4 2024Q3 2026
Total debt$22.2B +20.5% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$434.8B +8.0% 3M
Sample peer B
$396.9B +4.3% 3M
Sample peer C
$125.5B +0.6% 3M
Sample peer D
$595.5B +8.9% 3M
Sample peer E
$513.7B -10.1% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not ANIX's real figure. Nothing here is investment advice.